Auryxia® (ferric citrate) – New indication
November 7, 2017 – Keryx Biopharmaceuticals announced the FDA approval of Auryxia (ferric citrate) for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) not on dialysis.
Download PDF
